Foster City, CA, United States of America

Chung Nan Chang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 123(Granted Patents)


Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Chung Nan Chang

Introduction

Chung Nan Chang is a prominent inventor based in Foster City, CA, known for his significant contributions to the field of immunology. With a total of 10 patents to his name, he has made remarkable advancements in the treatment of various medical conditions through innovative methods.

Latest Patents

Chang's latest patents include groundbreaking methods of treating with anti-PSGL-1 antibodies. These patents detail immunoglobulin chains or antibodies that possess light or heavy chain complementarity determining regions, specifically targeting P-Selectin Glycoprotein Ligand-1. Additionally, he has disclosed methods for inducing the death of activated T-cells and modulating T cell-mediated immune responses in subjects. Another notable patent focuses on treating graft-versus-host disease (GVHD) and transplant rejection using similar anti-PSGL-1 antibodies.

Career Highlights

Throughout his career, Chung Nan Chang has worked with notable companies such as Abgenomics Cooperatief U.A. and Protein Design Labs, Inc. His work has significantly impacted the development of therapies aimed at improving patient outcomes in immunological disorders.

Collaborations

Chang has collaborated with esteemed colleagues, including Rong-Hwa Lin and Pei-Jiun Chen, contributing to the advancement of research in his field.

Conclusion

Chung Nan Chang's innovative work and numerous patents reflect his dedication to advancing medical science, particularly in immunology. His contributions continue to influence the development of effective treatments for complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…